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Summary
Background: The relationship between pregnancy and typhoid fever is not well defined. The
objective of this study was twofold: to assess the effect of the pregnant and postpartum host on
typhoid disease expression, and to explore the relationship between typhoid fever and pregnancy
outcome.
Methods: Over an 11-year period, all 181 adult women with blood culture-confirmed typhoid
fever admitted to a university hospital in Karachi, Pakistan were studied; those with pregnancy-
related disease were compared to the non-pregnant women. The relationship between typhoid
fever and pregnancy outcomewas evaluated by comparing 80 pregnant womenwith typhoid, with
194 randomly selected pregnant women without typhoid who were matched for age and study
year.
Results: In adult femaleswith bacteremic typhoid disease, a significant proportionwas pregnancy-
related (47%). These women were less likely to have other co-morbid illnesses (2% vs. 27%,
p < 0.001) and were almost exclusively treated with ampicillin/amoxicillin or third-generation
cephalosporins, while the non-pregnant women with typhoid fever preferentially received quino-
lones. Themean duration of antimicrobial therapywas similar in both groups (14 days) but the non-
pregnant group defervesced earlier (4.2 days vs. 5.6 days, p = 0.011). Complications of typhoid
fever were significantly more likely in the non-pregnant group (23% vs. 8%, p = 0.005) and primarily
involved lower gastrointestinal bleeding. On comparing the pregnant women with typhoid with
randomly selected age-matched pregnant womenwithout typhoid, therewere no apparent effects
of typhoid fever on pregnancy outcome as measured by gestational age at delivery, pregnancy
complications, modes of delivery, neonate gender, birth weight, or birth Apgar scores.
Conclusions: While pregnancy is a risk factor for and effects typhoid disease expression, typhoid
fever does not appear to affect pregnancy outcome.
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Typhoid, or enteric fever, is a distinctive acute systemic
febrile infection caused by several serotypes of the Gram-
negative bacillus Salmonella (primarily Salmonella choler-
aesuis serotypes typhi and paratyphi). Human carriers are the
only known reservoir of the disease that is spread through
contaminated food and water. Known global hotspots for
typhoid fever include Mexico, Peru, Egypt, Indonesia, India,
Pakistan and Nepal.
The hallmark of typhoid fever is a bacteremic illness asso-
ciated with prolonged, persistent fever lasting 4—8 weeks in
untreated patients. Complications include intestinal hemor-
rhage or perforation, pneumonia, myocarditis, hepatitis,
acute cholecystitis and meningitis. Following an initial recov-
ery, relapses occur in about 10—20% of untreated patients. The
diagnosis is confirmedby isolationof thebacteria fromablood,
urine, stool or bone marrow culture. Supportive laboratory
findings include anemia, normal or decreased white blood cell
count, diminished platelets, elevated aminotransferases (two
or three times normal levels), and fecal leukocytes in patients
with diarrhea. A two-week antibiotic coursewith chloramphe-
nicol, ampicillin or trimethoprim—sulfamethoxazole was the
mainstay of therapy until the emergence of multidrug-resis-
tant strains in Asia where quinolones and third-generation
cephalosporins are now gaining popularity.
Although the course and treatment of typhoid fever has
been widely researched, the relationship of the disease with
pregnancy is largely unknown. The aim of this study was
twofold: (1) to assess the effect of the pregnant and post-
partum host on typhoid disease expression, and (2) to explore
the relationship between typhoid fever and pregnancy out-
come.
Patients and methods
The studywas conducted at a 450-bed tertiary care university
hospital located in themegacity of Karachi, Pakistan. Over an
11-year period (1989—1999) all adult female patients (age
>14 years) with a clinical discharge diagnosis of typhoid fever
were identified using the ICD-9-CM codes. Records of 307
patients were retrieved, of whom 133 (43%) were pregnant or
postpartum (within 6 weeks of delivery). Of the 174 non-
pregnant women with presumed typhoid, 96 (55%) had posi-
tive blood cultures, while 85 (64%) of the 133 pregnant or
postpartum patients had culture-confirmed typhoid fever. To
assess the effect of the pregnant and postpartum host on
typhoid disease expression, the two groups with culture-
confirmed typhoid fever were compared. The effects of
typhoid fever on pregnancy outcome were explored by com-
paring 80 of the pregnant women with culture-confirmed
typhoid, with 194 age-matched randomly selected pregnant
women without typhoid taken from the over 40 000 patients
admitted to obstetrics services. All the patients in the study
were followed at the same institution during the entire
duration of pregnancy and received the same standard of
care throughout their pregnancy.
Statistical analysis
Data were abstracted using a questionnaire containing
information on the state of pregnancy, disease signs andsymptoms, relevant laboratory investigations, course of the
illness, and response to treatment. In addition, various
details of the pregnancy such as parity, outcome, complica-
tions, and details of delivery were also documented. Data
were entered and analyzed using SPSS. Categorical data
were compared using Chi-square tests while the indepen-
dent sample t-test was used to compare means. Results of
two-sided p < 0.05 were considered significant.
Results
Effect of the pregnant and postpartum host on
typhoid disease expression (Table 1)
Cases of typhoid fever were seen throughout the year with no
seasonal pattern in either group of women with culture-
confirmed disease. The average age in both groups was
approximately 25 years. Overall, 71% of the 181 women with
typhoid fever were infected with S. typhi. However, the
proportion of pregnant or postpartum women with S. typhi
(79%) was significantly higher than non-pregnant women
(64%). While most cases of typhoid fever in pregnancy
occurred in the second and third trimesters (75%), only
two cases occurred in the postpartum host.
Only two pregnant women with typhoid fever had any co-
morbid illness, one had a history of malaria in the last three
months while the other had had acute viral hepatitis in the
preceding six months. By comparison, 26 (27%) of the non-
pregnant women, a significantly higher number, presented
with co-morbid illnesses. These included diabetes mellitus,
hepatitis, asthma, pneumonia, malaria, thalassemia minor
and tuberculosis. Prior use of antibiotics was observed in a
total of 56% of all women with typhoid fever, and did not
differ significantly between the pregnant and non-pregnant
groups. The duration of fever prior to presentation was also
similar in both groups. The symptoms of typhoid disease were
assessed as upper gastrointestinal (nausea/vomiting), lower
gastrointestinal (diarrhea/constipation), and cough. Preg-
nant women were significantly more likely to present with
cough (36%), than non-pregnant women (21%), but were less
likely to report upper gastrointestinal symptoms.
Of the investigations done, no significant differences were
seen in the white blood cell or platelet counts. The mean
hemoglobin level in the pregnant patients was 10.8 g/dl,
significantly lower than the mean of 11.4 g/dl in the non-
pregnant group. Serum transaminase levels were also more
likely to be raised in the group with pregnancy-associated
typhoid fever.
The most popular choice of antimicrobial therapy in the
patients with pregnancy-associated typhoid was the third-
generation cephalosporins (56%), while non-pregnant
females with typhoid were predominantly treated with qui-
nolones (58%). Only five pregnancy-related typhoid patients
were given quinolones, three of whom were in their first
trimester and had aborted (prior to antibiotic administra-
tion), and the remaining two were postpartum patients.
Another popular choice for the women who were pregnant
was ampicillin/amoxicillin, administered to 31% of them
while only 9% in the non-pregnant group received this class
of antibiotics. Antibiotic therapy was prescribed for two
weeks in both groups. Fever after admission to hospital lasted
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Table 1 Culture-proven typhoid fever in a cohort of 181 adult women admitted to a tertiary care hospital (1988—1999)
Variable Study groups p Value (x2 or t-test)
Pregnancy-related
typhoid fever (N = 85)
Non-pregnant with
typhoid fever (N = 96)
Age in years (mean  SD) 25.8  4.9 24.3  6.4 0.077
Typhoid serotype
S. typhi 67 (79%) 61 (64%) 0.032
S. paratyphi 18 (21%) 35 (36%)
Fever duration prior to admission
(mean  SD)
12.4  12.5 14.2  16.8 0.419
History of prior antibiotic use 42 (49%) 59 (61%) 0.122
History of co-morbid illness 2 (2%) 26 (27%) <0.001
Symptoms
Nausea/vomiting 44 (52%) 69 (72%) 0.017
Diarrhea/constipation 32 (38%) 38 (40%) 0.833
Cough 31 (36%) 20 (21%) 0.020
Investigations
Hemoglobin mg/dl (mean  SD) 10.8  1.4 11.4  1.6 0.018
White cell count  103/ml (mean  SD) 7.3  2.1 7.6  4.0 0.494
Platelets  103/ml (mean  SD) 207  75 223  96 0.285
Raised transaminases 22/32 (69%) 26/61 (43%) 0.017
Antibiotics used
Ampicillin/amoxicillin 26 (31%) 9 (9%) <0.001
Third-generation cephalosporin 48 (56%) 17 (18%)
Quinolone 5 (6%) 56 (58%)
Other 2 (2%) 14 (15%)
Mean duration of antibiotics (mean  SD) 14.1  3.5 13.1  5.6 0.186
Duration of fever after admission 5.6  3.9 4.2  2.7 0.011
Relapse of typhoid 2/80 (3%) 1/95 (1%) 0.460
Complications of typhoid 6/80 (8%) 22 (23%) 0.005an average of 5.6 days in women with pregnancy-related
typhoid, significantly longer than the 4.2 days in those who
were not pregnant. While relapse rates were similar in both
groups, complications of typhoid fever were significantly
higher in non-pregnant women (23% versus 8%, p = 0.005).
Complications in the pregnancy-related group included three
cases of lower gastrointestinal bleeding and single cases of
sepsis, sepsis with disseminated intravascular coagulation,
and cholecystitis. Lower gastrointestinal bleeding was also
the most common complication in the non-pregnant group,
observed in 13 women. Other complications included sepsis,
liver abscess, psychosis, myocarditis and pancreatitis. There
were no fatalities in either group.
Effect of typhoid disease on pregnancy outcome
(Table 2)
Of the 85 pregnancy-associated typhoid fever cases, the five
that had had first trimester abortions (3) or were postpartum
(2) were excluded from the comparison with the age-
matched randomly selected group of 194 pregnant women
without typhoid fever. Both groups were similar in their
gravid status. No significant differences were seen between
the two groups in complications of pregnancy, modes of
delivery, and details of the live born. There were morefemales born to the pregnant women with typhoid but this
difference was not statistically significant.
Discussion
Given that 47% (85/181) of all adult women with culture-
confirmed typhoid fever admitted to the hospital in the 11-
year study period were pregnant or postpartum, pregnancy
seems to exert some effect on the presentation and course of
typhoid fever.
This raises the issue that amongst women with typhoid,
pregnancy status should be assessed prior to embarking on
antimicrobial therapy that may include quinolones. Olu-
buyide too, in a review of postmortem typhoid cases recog-
nized pregnancy as a distinct risk group for typhoid in adult
patients.1
Interestingly, pregnant women were more likely to be
infected with S. typhi than S. paratyphi, raising the issue
of increased virulence of S. typhi compared to S. paratyphi in
this susceptible population. In a sample of 114 adults (with
twice as many males as females) with culture-confirmed
typhoid fever, admitted to the same study hospital between
1993 and 1997, 64% was due to S. typhi and 34% was due to S.
paratyphi; this is similar to the distribution in the non-
pregnant women with typhoid (unpublished data, personal
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Table 2 Effect of typhoid fever on pregnancy
Variable Study group p Value (x2 or t-test)
Pregnant with typhoid
fever (N = 80)
Pregnant without typhoid
fever (N = 194)
Age in years (mean  SD) 25.8  4.9 26.2  4.9 0.595
Gravid 2.4  1.4 2.2  1.8 0.478
Gestational age at delivery in
weeks (mean  SD)
38.1  2.7 38.1  3.4 0.942
Pregnancy complications
None 69 (86%) 159 (82%) 0.319
Spotting 3 (4%) 11 (6%)
Miscarriage 5 (6%) 19 (10%)
Premature delivery 5 (6%) 5 (3%)
Pregnancy outcome
Abortion/still birth 4/60 (7%) 28/192 (15%) 0.108
Live birth 56/60 (93%) 164/192 (85%)
Mode of delivery
Spontaneous vaginal 46/54 (85%) 124/165 (75%) 0.125
Cesarean section 8/54 (15%) 41/165 (25%)
Gender of infant
Male 18/50 (36%) 80/165 (48%) 0.120
Female 32/50 (64%) 85/165 (52%)
Birth weight in kg (mean  SD) 2.9  0.6 3.0  0.5 0.125
Birth Apgar scores
1 minute 7.8  1.1 5.6  1.5 0.122
5 minutes 8.9  1.3 8.7  1.6 0.467communication with Dr Rumina Hassan, Department of Micro-
biology, Aga Khan University Hospital, Karachi, Pakistan).
Presenting symptoms among patients with typhoid dif-
fered between the groups. While pregnant women with
typhoid were more likely to present with cough, non-preg-
nant patients reported nausea/vomiting more often than
their pregnant counterparts did. Although nausea and vomit-
ing are often associated with the first trimester of pregnancy,
the majority of the pregnant patients (75%) presented in
their second and third trimesters.
The antibiotics used to treat typhoid fever were markedly
different in women who were pregnant compared to those
who were not. The most popular choices of antibiotics for the
pregnant patients were third-generation cephalosporins and
ampicillin/amoxicillin, while quinolones, widely believed to
be the drugs of choice for typhoid fever, were preferentially
used in the non-pregnant group. The latter are often avoided
in pregnancy due to the potential risk of toxicity to fetal
skeletal structures. However, ciprofloxacin has recently been
advocated as a safe drug to use in pregnancy by Koul et al.,
who based this recommendation on a case series of seven
pregnant patients treated with the drug, all of whom safely
delivered healthy babies.2 Oral ciprofloxacin produces more
rapid and reliable resolution of fever than does parenteral
ceftriaxone,3 and this fact, coupled with reports of increased
multidrug resistance in typhoid fever, as high as 100% in
Rawalpindi, Pakistan,4 and 96% in Bangalore, India,5 has
led to an increased use of fluoroquinolones. However, in
the present study only five patients in the pregnant categoryreceived fluoroquinolones, of whom two were postpartum
and three presented after spontaneous abortions in the first
trimester. The shorter time to defervescence in the non-
pregnant typhoid patient may, in part, be due to the pre-
ferential use of quinolones in this group.
The fact that non-pregnant women with typhoid were
more likely to develop complications invokes the hypothesis
that disease complications are related to host immunity and
less likely to occur with the immunological changes asso-
ciated with pregnancy. Pregnancy is associated with a strong
skewing towards T-helper 2 cytokine pattern, which enables
the survival of the fetus6 and this may give protection against
typhoid-related intestinal hemorrhage and perforation. To
the best of our knowledge, the specific risk factors that
predispose to complications of typhoid disease in adults have
not been clearly elucidated and this is an area that needs
more work.
It has previously been suggested that typhoid fever may
have an adverse effect on the outcome of pregnancy. A case
series of five pregnancies complicated by typhoid fever con-
ducted in Mexico in 1994 did document one abortion and one
preterm delivery resulting in neonatal death.7 The authors
suggested proper diagnosis and early treatment as the cor-
nerstones of preventing such outcomes. The data presented
here, however, show no significant differences in complica-
tions of pregnancy, outcomes, and markers of neonatal well
being between pregnant women who developed typhoid
fever and randomly selected pregnant women who did not
have the disease.
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This study suggests that while pregnancy is an important risk
factor for acquiring typhoid in adults and appears to modify
disease expression, the disease itself may not affect preg-
nancy or its outcome in any significant way. However, these
findings should be verified prospectively given the inherent
biases associated with our retrospective study at a tertiary
care institution where only the sicker pregnant women would
be expected to seek care.
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